Results 151 to 160 of about 25,012 (219)

Exploring the potential of psychedelics in brain injury recovery: a thematic analysis of participant narratives [PDF]

Oliver Reed
openalex   +1 more source

Psychedelic Medicine Exceptionalism

Research on psychedelic medicines is experiencing a revival. Some clinicians, scientists, and ethicists believe that psychedelics are so different from other treatments that they warrant special consideration in how they are researched, regulated ...
Marks, Mason, Cohen, I. Glenn
core  

Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs. [PDF]

ACS Chem Neurosci
Ippolito A, Tiranti A, Hurley S, Gilmour G, Churchill G, Sharp T.   +5 more
europepmc   +1 more source

Level of preparedness to use psilocybin among individuals seeking psychedelic risk reduction: a retrospective study of a pilot psychiatric consultation service [PDF]

Harland V. Harrison, Mizan Gaillard, Ryan R. Cook, Aryan Sarparast, Ximena A. Levander   +4 more
openalex   +1 more source

US federal aggregate production quotas for psychedelic substances, 2013 to 2026

H. Tamba
  +4 more sources

Oncology Providers' Perspectives on Psychedelic-Assisted Therapy. [PDF]

Am J Hosp Palliat Care
Hanubal KS, Munjal AN, Park J, Banks R, Choi E, Hoyt MA, Humphreys JN, Mojtahedzadeh M, Harris JP.   +8 more
europepmc   +1 more source

Psychedelics in Mental Health: Opportunities and Challenges. [PDF]

Brain Behav
Oestreich LKL, Rieser NM.
europepmc   +1 more source

Memory experiences under psychedelics – an exploratory prospective online study

Samuli Kangaslampi, Kim P. C. Kuypers
openalex   +1 more source

Psychedelics and Ibogaine "Pain Medications" at the Pharmacy Counter: Implications for Pharmacy Practice. [PDF]

J Pain Res
Breve F, Berenato FJ, Pergolizzi JV, Varrassi G, Raffa RB.   +4 more
europepmc   +1 more source

An Integrative Somatic Approach to Psychedelic-Assisted Therapy: Theoretical Foundations and Biological Mechanisms

Devon Christie, Manesh Girn
openalex   +1 more source